Anticonvulsant activity of paeonimetabolin-I adducts obtained by incubation of paeoniflorin and thiol compounds with Lactobacillus brevis

Biological and Pharmaceutical Bulletin

Volumn 22, Issue 5, 1999, Pages 491-497

  Abdel Hafez, Atef A ^b   Meselhy, Meselhy R ^a   Nakamura, Norio ^a   Hattori, Masao ^a   Watanabe, Hiroshi ^a   Murakami, Yukihisa ^a   El Gendy, Mahmoud A ^b   Mahfouz, Nadia M ^b   Mohamed, Tarek A ^b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b Assiut University   (Egypt)

Author keywords

Anticonvulsant; Lactobacillus brevis; Paeoniflorin; Pentylenetetrazole induced seizure; Thiopaeonimetabolin I adduct

Indexed keywords

8 (4 TOLYLTHIO)PAEONIMETABOLIN 1; 8 (N HEXYLTHIO)PAEONIMETABOLIN 1; 8 BENZOYLTHIOPAEONIMETABOLIN 1; 8 CYCLOPENTYLTHIOPAEONIMETABOLIN 1; ANTICONVULSIVE AGENT; PAEONIFLORIN; PENTETRAZOLE; THIOL DERIVATIVE; UNCLASSIFIED DRUG; VALPROIC ACID;

ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; ARTICLE; CLONIC SEIZURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; LACTOBACILLUS BREVIS; MALE; MOUSE; MUSCLE RELAXATION; NONHUMAN; STEREOISOMERISM; SUBCUTANEOUS DRUG ADMINISTRATION; TONIC SEIZURE;

EID: 0033014660     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.22.491     Document Type: Article

References (13)

1. Pevarello P., Bonsignori A., Dostert P., Heidmpergher F., Priciroli V., Colombo M., McArthur R. A., Salvati P., Post C., Fariello R. G., Varasi M., J. Med. Chem., 41, 579-590 (1998).
2. Lascher W., Nau H., Neuropharmacology, 24, 427 -435 (1985).
3. Shu Y. Z., Hattori M., Namba T., Mibu K., Akao T., Kobashi K., J. Pharmacobio-Dyn., 10, s-58 (1987).
4. Akao T., Shu Y. Z., Matsuda Y., Hattori M., Namba T., Kobashi K., Chem. Pharm. Bull., 36, 3043-3048 (1988).
5. Kaneda M., Iilaka Y., Shibata S., Tetrahedron, 28, 4309-4317 (1972).
6. Ahmad A., Dhawan B. N., Jpn. J. Pharmacol., 19, 472-474, (1969).
7. Swinyard E. A., "Anticonvulsant Drugs, International Encyclopedia of Pharmacology and Therapeutics," Section 19, Vol. 1, ed. by Mercier J., Pergamon Press, Oxford/New York, 1972, pp. 47-65.
8. Dunham N. W., Miya T. S., J. Am. Pharm. Assoc., XLVI, 208-209 (1957).
9. Shu Y., Hattori M., Akao T., Kobashi K., Kagei K., Fukuyama K., Tsukihara T., Namba T., Chem. Pharm. Bull., 35, 3726-3733 (1987).
10. Bruce R. D., Fund. Appl. Toxicol., 5, 151-157 (1985).
11. Kiuchi F., Noguchi H., Iitaka Y., Sankawa U., Tetrahedron Lett., 22, 3069-3070 (1981).
12. Shimizu M., Hayashi T., Morita N., Kiuchi F., Noguchi H., Iitaka Y., Sankawa U., Chem. Pharm. Bull., 31, 577-583 (1983).
13. Heikal O. A., Akao T., Takeda S., Hattori M., Biol. Pharm. Bull., 20, 517-521 (1997).